151 related articles for article (PubMed ID: 24126694)
1. Lanthanum carbonate stimulates bone formation in a rat model of renal insufficiency with low bone turnover.
Fumoto T; Ito M; Ikeda K
J Bone Miner Metab; 2014 Sep; 32(5):484-93. PubMed ID: 24126694
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
3. Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormone.
Inaba M; Okuno S; Nagayama H; Yamada S; Ishimura E; Imanishi Y; Shoji S
J Ren Nutr; 2015 Mar; 25(2):242-6. PubMed ID: 25556148
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone.
Iwasaki-Ishizuka Y; Yamato H; Nii-Kono T; Kurokawa K; Fukagawa M
Nephrol Dial Transplant; 2005 Sep; 20(9):1904-11. PubMed ID: 15985520
[TBL] [Abstract][Full Text] [Related]
5. Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure?
Behets GJ; Dams G; Vercauteren SR; Damment SJ; Bouillon R; De Broe ME; D'Haese PC
J Am Soc Nephrol; 2004 Aug; 15(8):2219-28. PubMed ID: 15284308
[TBL] [Abstract][Full Text] [Related]
6. Comparison of peripheral bone and body axis skeleton in a rat model of mild-to-moderate renal failure in the presence of physiological serum levels of calcitropic hormones.
Freesmeyer MG; Abendroth K; Faldum A; Krauss C; Stein G
Bone; 2001 Sep; 29(3):258-64. PubMed ID: 11557370
[TBL] [Abstract][Full Text] [Related]
7. Utilization of bone histomorphometry in renal osteodystrophy: demonstration of a new approach using data from a prospective study of lanthanum carbonate.
Freemont T; Malluche HH
Clin Nephrol; 2005 Feb; 63(2):138-45. PubMed ID: 15730056
[TBL] [Abstract][Full Text] [Related]
8. Effects of lanthanum carbonate on bone markers and bone mineral density in incident hemodialysis patients.
Goto K; Goto S; Fujii H; Watanabe K; Kono K; Nishi S
J Bone Miner Metab; 2019 Nov; 37(6):1075-1082. PubMed ID: 31214836
[TBL] [Abstract][Full Text] [Related]
9. Lycopene treatment against loss of bone mass, microarchitecture and strength in relation to regulatory mechanisms in a postmenopausal osteoporosis model.
Ardawi MM; Badawoud MH; Hassan SM; Rouzi AA; Ardawi JMS; AlNosani NM; Qari MH; Mousa SA
Bone; 2016 Feb; 83():127-140. PubMed ID: 26549245
[TBL] [Abstract][Full Text] [Related]
10. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
Sato M; Zeng GQ; Turner CH
Endocrinology; 1997 Oct; 138(10):4330-7. PubMed ID: 9322947
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.
Ota M; Takahata M; Shimizu T; Kanehira Y; Kimura-Suda H; Kameda Y; Hamano H; Hiratsuka S; Sato D; Iwasaki N
Osteoporos Int; 2017 Apr; 28(4):1481-1490. PubMed ID: 27933339
[TBL] [Abstract][Full Text] [Related]
12. Assessment of effects of lanthanum carbonate with and without phosphate supplementation on bone mineralization in uremic rats.
Damment SJ; Shen V
Clin Nephrol; 2005 Feb; 63(2):127-37. PubMed ID: 15730055
[TBL] [Abstract][Full Text] [Related]
13. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ
Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory Bowel Disease in a Rodent Model Alters Osteocyte Protein Levels Controlling Bone Turnover.
Metzger CE; Narayanan A; Zawieja DC; Bloomfield SA
J Bone Miner Res; 2017 Apr; 32(4):802-813. PubMed ID: 27796050
[TBL] [Abstract][Full Text] [Related]
15. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Meng Y; Zhang H; Li Y; Li Q; Zuo L
Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
[TBL] [Abstract][Full Text] [Related]
16. Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency.
Miller MA; Chin J; Miller SC; Fox J
Bone; 1998 Sep; 23(3):257-66. PubMed ID: 9737348
[TBL] [Abstract][Full Text] [Related]
17. Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease--role of sclerostin?
Ferreira JC; Ferrari GO; Neves KR; Cavallari RT; Dominguez WV; Dos Reis LM; Graciolli FG; Oliveira EC; Liu S; Sabbagh Y; Jorgetti V; Schiavi S; Moysés RM
PLoS One; 2013; 8(11):e79721. PubMed ID: 24236156
[TBL] [Abstract][Full Text] [Related]
18. Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats.
Ominsky MS; Brown DL; Van G; Cordover D; Pacheco E; Frazier E; Cherepow L; Higgins-Garn M; Aguirre JI; Wronski TJ; Stolina M; Zhou L; Pyrah I; Boyce RW
Bone; 2015 Dec; 81():380-391. PubMed ID: 26261096
[TBL] [Abstract][Full Text] [Related]
19. Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption.
Chandler H; Lanske B; Varela A; Guillot M; Boyer M; Brown J; Pierce A; Ominsky M; Mitlak B; Baron R; Kostenuik P; Hattersley G
Bone; 2019 Mar; 120():148-155. PubMed ID: 30343166
[TBL] [Abstract][Full Text] [Related]
20. Negative effect of serotonin-norepinephrine reuptake inhibitor therapy on rat bone tissue after orchidectomy.
Fekete S; Simko J; Mzik M; Karesova I; Zivna H; Zivny P; Pavliková L; Palicka V
Eur J Pharmacol; 2015 Aug; 761():65-9. PubMed ID: 25934570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
